Patents by Inventor Anton Beletskii
Anton Beletskii has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10131874Abstract: A cell culture support comprising a substrate, and a dual stimuli responsive block copolymer immobilized on the substrate, wherein the dual stimuli responsive block copolymer is both thermoresponsive and pH responsive. A method of culturing cells comprising the cell culture support having a dual stimuli responsive copolymer immobilized on a substrate, wherein the dual stimuli responsive copolymer is thermoresponsive and pH responsive; and growing the cells on the cell culture support. By lowering the temperature, cells are released from the cell culture support.Type: GrantFiled: September 12, 2016Date of Patent: November 20, 2018Assignee: GENERAL ELECTRIC COMPANYInventors: Reginald Donovan Smith, Prameela Susarla, Slawomir Rubinsztajn, Brian David Polizzotti, Anton Beletskii
-
Publication number: 20160376550Abstract: A cell culture support comprising a substrate, and a dual stimuli responsive block copolymer immobilized on the substrate, wherein the dual stimuli responsive block copolymer is both thermoresponsive and pH responsive. A method of culturing cells comprising the cell culture support having a dual stimuli responsive copolymer immobilized on a substrate, wherein the dual stimuli responsive copolymer is thermoresponsive and pH responsive; and growing the cells on the cell culture support. By lowering the temperature, cells are released from the cell culture support.Type: ApplicationFiled: September 12, 2016Publication date: December 29, 2016Inventors: Reginald Donovan Smith, Prameela Susarla, Slawomir Rubinsztajn, Brian David Polizzotti, Anton Beletskii
-
Patent number: 9469839Abstract: A cell culture support comprising a substrate, and a dual stimuli responsive block copolymer immobilized on the substrate, wherein the dual stimuli responsive block copolymer is both thermoresponsive and pH responsive. A method of culturing cells comprising the cell culture support having a dual stimuli responsive copolymer immobilized on a substrate, wherein the dual stimuli responsive copolymer is thermoresponsive and pH responsive; and growing the cells on the cell culture support. By lowering the temperature, cells are released from the cell culture support.Type: GrantFiled: June 29, 2009Date of Patent: October 18, 2016Assignee: General Electric CompanyInventors: Slawomir Rubinsztajn, Prameela Susarla, Anton Beletskii, Reginald Donovan Smith, Brian Polizzotti
-
Publication number: 20120208268Abstract: The present invention relates to a separation media and a method for separation of cells from different cell sources, such as umbilical cord blood, using the separation media to obtain the desired cells, such as stem cells. The separation media has beads with a diameter of 200-500 ?m and is provided with cell separation ligands. The cell specific ligands are preferably CD3 and CD19 for depletion of B and T cells and production of a stem cell rich product.Type: ApplicationFiled: April 26, 2012Publication date: August 16, 2012Applicant: GE HEALTHCARE BIO-SCIENCES ABInventors: ANDREAS AXÉN, ANTON BELETSKII, FREDRIK ELWINGER, GUNNAR HAGSTRÖM, DEIDRE A. NELSON
-
Publication number: 20120156777Abstract: A carrier for growing adherent cells is provided, wherein the carrier comprises one or more outer surfaces; and one or more structured indentations on one or more of the outer surfaces, wherein the carrier has a length at least about 0.2 mm, a width at least about 0.2 mm, and a height in a range from about 0.05 mm to 1.2 mm and each of the structured indentations has a major axis in a range from about 0.1 mm to 0.5 mm, a minor axis in a range from about 0.1 mm to 0.5 mm and a depth in a range from about 0.025 mm to about 0.5 mm. The carrier may comprise a single indentation or ‘cup’ like structure, or may comprise a plurality of indentations. A method of making the carrier, and culturing stromal cells using the same carrier are also provided.Type: ApplicationFiled: December 16, 2010Publication date: June 21, 2012Applicant: GENERAL ELECTRIC COMPANYInventors: Arvind Rangarajan, Prameela Susarla, Scott Michael Miller, Reginald Donovan Smith, Slawomir Rubinsztajn, Anton Beletskii
-
Patent number: 7906106Abstract: Provided herein are methods of monitoring inflammatory cell migration in a mammal. The methods include the steps of: providing a donor mammalian subject; introducing an inflammatory agent into the donor mammal to create a granuloma; isolating granuloma-derived nucleated cells from the granuloma of the donor mammalian subject; labeling the granuloma-derived nucleated cells with an optical agent; providing a recipient mammalian subject with inflamed tissue; introducing the granuloma-derived nucleated cells into a recipient mammalian subject at a site remote from site where the inflammatory agent was introduced; and imaging the recipient mammalian subject using an optical system. The methods may also include analysing the distribution of the labeled granuloma-derived cells in the recipient mammal.Type: GrantFiled: June 27, 2007Date of Patent: March 15, 2011Assignee: General Electric CompanyInventors: Eric Dustin Agdeppa, Srabani Bhaumik, June Klimash, Jeannette Christine DePuy, Anton Beletskii
-
Publication number: 20100330674Abstract: A cell culture support comprising a substrate, and a dual stimuli responsive block copolymer immobilized on the substrate, wherein the dual stimuli responsive block copolymer is both thermoresponsive and pH responsive. A method of culturing cells comprising the cell culture support having a dual stimuli responsive copolymer immobilized on a substrate, wherein the dual stimuli responsive copolymer is thermoresponsive and pH responsive; and growing the cells on the cell culture support. By lowering the temperature, cells are released from the cell culture support.Type: ApplicationFiled: June 29, 2009Publication date: December 30, 2010Applicant: GENERAL ELECTRIC COMPANYInventors: Slawomir Rubinsztajn, Prameela Susarla, Anton Beletskii, Reginald Donovan Smith, Brian Polizzotti
-
Patent number: 7846735Abstract: Provided herein are compositions and methods for lipoprotein uptake assay. These compositions and methods may be used for lipoprotein uptake assays, including high-throughput assays. The disclosed compositions and method may further be used to characterize the activity agents that inhibit or stimulate lipoprotein uptake.Type: GrantFiled: August 22, 2007Date of Patent: December 7, 2010Assignee: General Electric CompanyInventors: Anton Beletskii, Liming Lu, Jason William Castle
-
Publication number: 20100081121Abstract: The present invention relates to a separation media and a method for separation of cells from different cell sources, such as umbilical cord blood, using the separation media to obtain the desired cells, such as stem cells. The separation media has beads with a diameter of 200-500 ?m and is provided with cell separation ligands. The cell specific ligands are preferably CD3 and CD19 for depletion of B and T cells and production of a stem cell rich product.Type: ApplicationFiled: January 28, 2008Publication date: April 1, 2010Applicant: GE HEALTHCARE BIO-SCIENCES ABInventors: Andreas Axen, Anton Beletskii, Fredrik Elwinger, Gunnar Hagstrom, Deidre A. Nelson
-
Publication number: 20090004115Abstract: Provided herein are methods of monitoring inflammatory cell migration in a mammal. The methods include the steps of: providing a donor mammalian subject; introducing an inflammatory agent into the donor mammal to create a granuloma; isolating granuloma-derived nucleated cells from the granuloma of the donor mammalian subject; labeling the granuloma-derived nucleated cells with an optical agent; providing a recipient mammalian subject with inflamed tissue; introducing the granuloma-derived nucleated cells into a recipient mammalian subject at a site remote from site where the inflammatory agent was introduced; and imaging the recipient mammalian subject using an optical system. The methods may also include analysing the distribution of the labeled granuloma-derived cells in the recipient mammal.Type: ApplicationFiled: June 27, 2007Publication date: January 1, 2009Applicant: GENERAL ELECTRIC COMPANYInventors: Eric Dustin Agdeppa, Srabani Bhaumik, June Klimash, Jeannette Christine DePuy, Anton Beletskii
-
Publication number: 20080044352Abstract: Provided herein are compositions and methods for lipoprotein uptake assay. These compositions and methods may be used for lipoprotein uptake assays, including high-throughput assays. The disclosed compositions and method may further be used to characterize the activity agents that inhibit or stimulate lipoprotein uptake.Type: ApplicationFiled: August 22, 2007Publication date: February 21, 2008Applicant: GENERAL ELECTRIC COMPANYInventors: Anton Beletskii, Liming Lu, Jason Castle
-
Patent number: 7279296Abstract: Provided herein are compositions and methods for lipoprotein uptake assay. These compositions and methods may be used for the lipoprotein uptake assays, including high-throughput assays. The disclosed compositions and method may further be used to characterize the activity agents that inhibit or stimulate lipoprotein uptake.Type: GrantFiled: December 16, 2005Date of Patent: October 9, 2007Assignee: General Electric CompanyInventors: Anton Beletskii, Liming Yu, Jason William Castle
-
Publication number: 20070141551Abstract: Provided herein are compositions and methods for lipoprotein uptake assay. These compositions and methods may be used for the lipoprotein uptake assays, including high-throughput assays. The disclosed compositions and method may further be used to characterize the activity agents that inhibit or stimulate lipoprotein uptake.Type: ApplicationFiled: December 16, 2005Publication date: June 21, 2007Inventors: Anton Beletskii, Liming Yu, Jason Castle
-
Publication number: 20070140974Abstract: In some embodiments, the present invention is directed to novel targeted contrast agents for magnetic resonance imaging (MRI). The present invention is also directed to methods of making such targeted MRI contrast agents, and to methods of using such MRI contrast agents. Typically, such targeted MRI contrast agents provide enhanced relaxivity, improved signal-to-noise, targeting ability, and resistance to agglomeration. Methods of making such MRI contrast agents typically afford better control over particle size, and methods of using such MRI contrast agents typically afford enhanced blood clearance rates and biodistribution.Type: ApplicationFiled: December 15, 2005Publication date: June 21, 2007Applicant: General Electric CompanyInventors: Andrew Torres, Faisal Syud, Nichole Wood, Amit Kulkarni, Mark Baillie, Bahram Moasser, Brian Bales, Anton Beletskii, Peter Bonitatebus
-
Publication number: 20070065805Abstract: The present invention provides compositions and methods for preparation of a three-dimensional transendothelial cell migration (TEM) assay. These compositions and methods are uniquely suited for the high throughput TEM assay, and for the analysis and identification of TEM mediators which inhibit or stimulate this process. The composition for detecting migration of cells comprises a solid layer comprising collagen gel; a first cellular layer in contact with the solid layer and comprising a first cell type; and a second cell type seeded on top of the first cellular layer. Optionally, gelatin is included in the collagen gel. A 96 well plate format is disclosed, the combination with a high throughput cellular scanner enables high throughput TEM assay.Type: ApplicationFiled: September 12, 2006Publication date: March 22, 2007Inventors: Liming Yu, Lihong Zhao, Anton Beletskii, Padma Channavajhala
-
Publication number: 20060093555Abstract: The present invention is directed to the field of magnetic resonance imaging (MRI) using superparamagnetic iron oxide (SPIO) agents. In particular, the present invention is directed to cationic, nonagglomerated, nontoxic SPIO agents, methods for imaging conditions associated with inflammatory responses using the disclosed SPIO agents, and methods for managing inflammatory conditions using the disclosed SPIO agents.Type: ApplicationFiled: November 1, 2005Publication date: May 4, 2006Inventors: Andrew Torres, Brian Bales, Peter Bonitatebus, Amit Kulkarni, William Dixon, Lisa Schoonmaker, Patrick Malenfant, Anton Beletskii, Matthew Morrison